Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder CancerJ Urol 2022 Jan 01;207(1)70-76, D D'Andrea, PC Black, H Zargar, CP Dinney, F Soria, MS Cookson, JS Montgomery, W Kassouf, MA Dall'Era, SS Sridhar, JS McGrath, JL Wright, AC Thorpe, JM Holzbeierlein, DM Carrión, E Di Trapani, TJ Bivalacqua, S North, DA Barocas, Y Lotan, P Grivas, AJ Stephenson, BW van Rhijn, S Daneshmand, PE Spiess, SF Shariat
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.